CompletedPHASE1, PHASE2NCT00032162
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
Studying Carcinosarcoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AGO Study Group
- Principal Investigator
- Andreas du Bois, MD, PhDDr. Horst-Schmidt-Kliniken
- Intervention
- carboplatin(drug)
- Enrollment
- 63 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2001
Study locations (19)
- Universitaetsklinikum Charite, Berlin, Germany
- Zentralkrankenhaus, Bremen, Germany
- Medizinische Klinik I, Dresden, Germany
- Universitaetsklinik Duesseldorf, Düsseldorf, Germany
- Evangelisches Krankenhaus, Düsseldorf, Germany
- Klinikum der J.W. Goethe Universitaet, Frankfurt, Germany
- Staedtisches Krankenhaus FFM-Hoechst, Frankfurt am Main, Germany
- Universitaetsklinik Goettingen, Göttingen, Germany
- Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, Germany
- Frauenklinik der MHH, Hanover, Germany
- Vincentius Krankenhaus, Karlsruhe, Germany
- Christian-Albrechts University of Kiel, Kiel, Germany
- Klinik der Otto - v. - Guericke - Universitat, Magdeburg, Germany
- Klinikum Grosshadern, Munich (Muenchen), Germany
- Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich (Muenchen), Germany
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00032162 on ClinicalTrials.gov